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Abstract: 
Despite the identification of master regulators of stem cell homeostasis, Sox2, Nanog, and 
Oct4, many mechanisms underlying the maintenance of self-renewal and pluripotency in 
embryonic stem cells are not well understood (Boyer et al. 2005, Cinghu et al. 2014). The 
proteins of the box H/ACA snoRNP have been identified as potentially of importance for stem 
cell maintenance (Cinghu et al. 2014) and are connected to regulation of stem cell-related gene 
expression (Fong et al. 2014), maintenance of self-renewal (Zhang et al. 2016), and accurate 
differentiation of stem cells (Bellodi et al. 2013). Using RNAi we investigated the connection 
between two members of the box H/ACA snoRNP, Dkc1 and Nop10, and stem cell homeostasis. 
We found that loss of Dkc1 lead to a disruption in stem cell homeostasis. To investigate if this 
connection was due to the pseudouridylation function of Dkc1, we constructed a genetic system 
to rescue the stem cell phenotype in Dkc1 knockdown. While we were able to establish 
exogenous expression of Dkc1 in our rescue system, the expression levels were not sufficient to 
rescue the loss of stem cell phenotype, requiring further optimization. Although we were not able 
to determine if pseudouridylation by the box H/ACA snoRNP is essential for stem cell 
homeostasis, we were able to demonstrate that this complex is important for the maintenance of a 
stem cell state.  
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 Embryonic stem cells (ESCs) are derived from the epiblast lineage of the blastocyst and 
have the developmental potential to differentiate into all three primary germ layers, defined as 
pluripotency. This ability, along with the capacity for self-renewal, are the key features defining 
ESCs (Czechanski et al 2014). These properties also make ESCs a particularly useful system for 
studying development and modelling disease, as they can be expanded in culture indefinitely and 
can be theoretically directed toward any lineage. The identification of regulators of stem cell 
homeostasis, which includes maintenance of stem cell gene expression profile, the ability to self 
renew, and pluripotency, is essential to fully understand these unique cells and can help 
researchers further understand development and disease. 
Cell identity is maintained by key regulators, often transcription factors, that maintain the 
gene expression profile of a specific cell type and control the induction of differentiation or 
transformation into new cell types. Functional studies have identified three transcription factors, 
Sox2, Nanog, and Oct4 as the core regulators in the maintenance of a pluripotent state in ESCs 
(Chen et al 2008, Young 2011, Jaenisch and Young 2008, Ng and Surani 2011). The expression 
of these three transcription factors are frequently used as indicators of the pluripotent potential of 
ESCs. Despite the identification of these key transcription factors for maintaining self-renewal  
and pluripotency, mechanisms regulating these master regulators remain poorly understood 
(Boyer et al. 2005, Cinghu et al 2014). In an attempt to address this gap in knowledge, RNAi-
based screens have identified more than 400 genes with a role in ESC maintenance (Ivanoza et al 
2006, Fazzio, Huff, and Panning 2008, Hu et al 2009, Ding et al 2009, Chia et al 2010, Bilodeau 
et al 2009). However, establishing a consensus on identified genes between these various screens 
is not always straight-forward. Recently, a bioinformatics based screen attempted to establish a 
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unbiased method for identifying genes important for ESC identity (Cinghu et al. 2014). Of these 
genes, a large number are highly expressed in ESCs and downregulated during the course of 
differentiation. Interestingly, four genes that fall into this category are the genes encoding the 
four proteins of the box H/ACA snoRNP complex, which were all found to be in the top 1% of 
genes suspected to be of importance in stem cell maintenance (Cinghu et al 2014).  
 The mammalian box H/ACA snoRNP is a complex of four proteins, the pseudouridine 
synthase (PUS) dyskerin (Dkc1), Nop10, Nhp2, and Gar1, and a small nucleolar RNA known as 
the box H/ACA snoRNA (Figure 1A). Pseudouridine (Ψ) is the C5-glycoside isomer of uridine, 
formed from the breakage of the N1-glycosyl bond followed by a 180° rotation of the base and 
formation of the C5-glycosyl bond, and is particularly abundant in rRNA although Ψ can be 
found in tRNA and mRNA as well (Ge and Yu 2013, Carlile et al 2014, Lovejoy et al. 2014, 
Schwartz et al. 2014) (Figure 1B). This modification creates an additional hydrogen bonding 
site, which leads to a stabilizing effect of Ψ on RNA (Figure 1B). As with many other RNA 
modifications, the functions of Ψ are not yet well understood, but the process of 
pseudouridylation is dynamic and may play a regulatory role in response to cellular stressors 
(Carlile et al 2014, Courtes et al 2014, Lovejoy et al 2014, Schwartz et al 2014, Wu et al 2011). 
Additionally, the documented impacts of Ψ on RNA structure suggest a potential influence by 
post-transcriptional regulation including translation efficiency of mRNAs, ribosome pausing, and 
alteration of the genetic code by non-canonical base pairing (Carlile et al 2015). 
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Figure 1: (A) Schematic representation of the eukaryotic box H/ACA snoRNP, adapted from the archaeal Box 
H/ACA snoRNP structure (Watkins and Bohnsack 2011). The four proteins (Dkc1, Nop10, Nhp2, and Gar1) are 
bound to a box H/ACA snoRNA, which is named for the box H and box ACA sequences. The box H/ACA snoRNA 
has a double hairpin structure with two pseudouridylation pockets that can target different RNAs for 
pseudouridylation. (B) Structures of uridine and pseudouridine. Pseudouridine is a structural isomer of uridine in 
which the uracil ring has been rotated 180° about the N-3/C-6 axis, breaking the N-1 glycosyl bond and forming a 
C-5 glycosyl bond. This exposes a fourth hydrogen bonding site at N-1 (arrow). 
 
Dkc1 is an RNA-dependent PUS and functions as the catalytic element of the snoRNP 
complex, and is guided along with Nop10, Gar1, and Nhp2 to sites for pseudouridylation by the 
box H/ACA snoRNA (McMahon, Contreras and Ruggero 2015). While all four components of 
the box H/ACA snoRNP complex are required for efficient catalytic activity of Dkc1, previous 
studies have shown that the archaeal homolog of Dkc1, and to a lesser extent the Dkc1 homolog 
in S. cerevisiae, can catalyze pseudouridylation in the absence of Gar1 and the Nhp2 homolog. 
Nop10, however, is required for any pseudouridylation activity of Dkc1 (Charpentier, Muller and 
Branlant 2005, Li et al 2011).  
The box H/ACA snoRNP has previously been identified as a co-activator of Oct4/Sox2 
gene activation, including activation of Nanog expression in a human cell system (Fong et al 
2014).  This activity was attributed to direct binding of the box H/ACA snoRNP along with the 
XPC DNA repair complex to enhancer regions of activated genes, however researchers were not 
able to completely rule out the impact of other Dkc1 functions, particularly rRNA processing by 
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pseudouridylation, on stem cell phenotype (Fong et al 2014). Box H/ACA snoRNAs have been 
connected directly to proliferation and self-renewal of mesenchymal stem cells (Zhang et al. 
2016), strengthening the connection between the box H/ACA snoRNP to stem cell phenotype. 
Additionally, the catalytic activity of Dkc1, and therefore the pseudouridylation function of the 
box H/ACA snoRNP, has been implicated in accurate differentiation of hematopoietic stem cells 
(Bellodi et al. 2013).  
Pseudouridylation is the key function of the box H/ACA snoRNP. We hypothesize that 
pseudouridylation by the box H/ACA snoRNP is important for ESC homeostasis. Therefore, we 
aim to investigate the impact of Dkc1 and Nop10 on mouse (m)ESC homeostasis, and determine 
if this impact can be attributed to the pseudouridylation activity of the box H/ACA snoRNP.  
 
Materials and Methods 
Plasmid Preparation and Construction:  
Plasmids for RNAi by shRNA were constructed using the pLKO.1 - TRC cloning vector 
(Addgene plasmid #10878), which expresses shRNAs from a U6 promoter. ShRNA 
oligonucleotides (oligos) were designed for the knockdown of each of the target mRNAs (Dkc1, 
Nop10, and Trub1) and GFP, the negative control (Appendix Table 1). The pLKO vector was 
digested with AgeI-HF® (NEB, R3552S) and EcoRI-HF® (NEB, R3101S) in the CutSmart® 
Buffer (NEB, B7204), generating a 7 kb backbone fragment and releasing a 1.9 kb insert. The 
EcoRI-AgeI digested backbone was purified using the QIAquick PCR Purification Kit (Qiagen, 
28104) following the manufacturer’s protocol, dephosphorylated using Calf Intestinal Alkaline 
Phosphatase (CIP) (NEB, M0290S) in CutSmart® Buffer, and purified again using the QIAquick 
PCR Purification Kit. ShRNA oligos were annealed by incubating forward (2 µM) and reverse (2 
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µM) oligos in NEBuffer 2 (NEB, B7002S) at 95 °C for 4 minutes followed by gradual cooling to 
room temperature. Annealed oligos were phosphorylated using the T4 PNK enzyme (NEB, 
M0201S), cloned into the AgeI and EcoRI digested pLKO vector using T4 DNA ligase (NEB, 
M0202S), and transformed into One Shot™ Stbl3™ Chemically Competent E. coli 
(ThermoFisher, C737303). Transformed bacteria were plated on LB-Agar plates with ampicillin 
(100 µg/mL) and incubated at 37 °C overnight. Ampicillin resistant colonies were picked and 
grown in liquid culture containing ampicillin (100 µg/mL) overnight at 37 °C. Plasmids were 
isolated using the QIAprep Spin Miniprep Kit (Qiagen, 27104) according to manufacturer's 
instructions. Plasmids were confirmed by digest with NcoI (NEB, R0193S) and EcoRI-HF® 
(NEB, R3101S). Positive clones resulted in a 2 kb and a 5 kb fragment and were confirmed by 
sequencing with the pLKO seq 1 primer by the GENEWIZ sequencing company (Appendix 
Table 2). 
 The plasmid for overexpression of Dkc1 was generated by Dr. Kathleen McCann using 
gateway cloning in the pEF-DEST51 vector from the protein expression core facility (PECF) at 
NIEHS, which expresses Dkc1 with a C-terminal V5 tag from a EF-1α promoter. The pEF-
DEST51-Dkc1 vector (50 ng) was mutated by mutagenesis PCR with the primers in Appendix 
Table 3 at 2.5 ng/µL using PrimeSTAR® HS DNA Polymerase (Takara, R010A) (cycling 
conditions: step 1: 95°C, 5 min., step 2: 95°C, 30 min., step 3: 55°C, 1 min., step 4: 68°C, 1 
min./kb, repeat back to step 2 18x, step 5: 68°C, 5 min.) in a a Bio-Rad® T100™ Thermal 
Cycler. PCR products were digested with Dpn1 (NEB, R0176S), a restriction enzyme that 
cleaves only methylated DNA and would linearize the template DNA, and transformed into One 
Shot™ TOP10 Chemically Competent E. coli (ThermoFisher, C404003). Plasmid DNA was 
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isolated using methods described above. Mutations were confirmed by sequencing with the EF-
alpha seq 1 and Dkc1 seq 2 primers by GENEWIZ (Appendix Table 2). 
Cell Culture:  
Mouse embryonic stem cells (mESCs, MMRRC The Jackson Laboratory) were cultured 
on gelatin coated plates in ESGRO Complete PLUS Clonal Grade Medium (SF001-500P, 
Millipore Sigma). Cells were grown at 37 °C with 5% CO2 with daily media changes, regular 
passaging with Trypsin-EDTA (Invitrogen, 1540054), and plating at a density of 1.5 × 106 cells 
per 10 cm2 dish. For transfection experiments, cells were plated at a density of 3 x 105 cells per 
well in a gelatin coated 12-well plate (surface area: 4 cm²) in M15 medium (DMEM (Invitrogen, 
11965092) supplemented with 15% embryonic stem cell fetal bovine serum (Gibco, 16141079), 
10 mM 2-mercaptoethanol, 0.1 mM nonessential amino acids (Invitrogen, 11140050), 1X 
EmbryoMax nucleosides (Millipore, ES-008-D), and 0.01% Leukemia Inhibitory Factor (LIF) 
(Gemini, 400-495)) at the time of transfection. On day 0, mESCs were transfected with 1 µg 
plasmid DNA in 100 µL of Opti-MEM™ (ThermoFisher Scientific, 31985062) using 2 µL 
Lipofectamine 2000 Transfection Reagent (ThermoFisher Scientific, 12566014). For both 
knockdown and rescue experiments, cells were split 1:1 into gelatin-coated 6-well plates (surface 
area: 9 cm²) on day 1 post-transfection. Cells were selected using antibiotic containing media 
with either puromycin (1 µg/mL) for pLKO only experiments or both puromycin (1 µg/mL) and 
blasticidin (5 µg/mL) of pLKO and pEF-DEST51 co-transfection experiments on day 2 post-
transfection.   
RNA Extraction:  
RNA was extracted 4 days post-transfection using the RNeasy Mini Kit (Qiagen, 74104) 
with on-column DNA digestion (Qiagen, 79254) according to manufacturer’s instructions. 
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Concentration of RNA was measured by NanoDrop Spectrophotometer at 260 nm 
(ThermoFisher Scientific).  
Reverse Transcription and qPCR:  
cDNAs were generated from RNA (1 µg) extracts by reverse transcription using the 
iScript kit (Bio-Rad,1708890) according to the manufacturer’s instructions. qPCR was then 
performed on 10 µg of cDNA from each sample with primers presented in Appendix Table 4 at 
0.5 µM using the SsoAdvanced™ Universal SYBR® Green Supermix (Bio-Rad, 1735270) 
(cycling conditions: step 1: 95 °C, 30 s, step 2: 95 °C, 5 s, step 3: 60 °C, 10 s, repeat back to step 
2 44x) in a Bio-Rad® CFX384™ Real-Time PCR System.  
qPCR Data Analysis: 
 To analyze the RT-qPCR data the delta-delta Cq method was used (Livak and Schmittgen 
2001). The difference between the raw quantitation cycle (Cq) value for each gene of interest 
(Dkc1, Nop10, Trub1, Sox2, Nanog, and Oct4) and the housekeeping gene Actin was found for 
each sample to generate the delta Cq (ΔCq = Cq(gene of interest) – Cq(housekeeping gene)). The 
delta delta Cq was found by finding the difference between the delta Cq for a given gene for each 
sample and the delta Cq for that same gene for the control, cells transfected with shGFP (ΔΔCq 
= ΔCq(sample) – ΔCq(control)). To find the relative gene expression between the sample and the 
control, the fold expression was calculated by raising 2 to the power of the negative delta delta 
Cq (fold expression = 2-ΔΔCq). For each replicate these values were then averaged. Bar graphs 
presenting expression of genes from RT-qPCR were generated in GraphPad Prism 7. Statistical 
significance was determined by two-sided paired t-test with alpha = 0.05 (95% confidence). All 
error bars represent standard error of the mean (SEM).  
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Alkaline Phosphatase (AP) Staining: 
 Cells were fixed in 4% paraformaldehyde (Sigma-Aldrich, P6148) in phosphate-buffered 
saline (PBS). AP staining was performed for phenotypic assessment of mESCs in experimental 
conditions using the Alkaline Phosphatase Detection Kit (Millipore Sigma, SCR004) according 
to manufacturer’s protocol.  
Protein Extraction:  
Protein was isolated on day 2 post-transfection from cells that were not put under 
antibiotic selection, with the exception of the final western blot presented (Figure 7E), where 
protein was harvested from cells on day 4 post-transfection (after antibiotic selection). Cells were 
harvested with Trypsin-EDTA (0.25%) (Invitrogen, 1540054), neutralized with DMEM 
(Invitrogen, 11965092) supplemented with 10% FBS (Gibco, 16141079), pelleted by 
centrifugation (113 xg), and washed 2X with PBS. Cells were lysed with RIPA Lysis Buffer (50 
mM HEPES (pH 7.4), 100 mM NaCl, 1 mM EDTA (pH 8.0), 1% Triton X-100, 0.5% Sodium 
Deoxycholate, 0.1% SDS) supplemented with 2X Halt™ Protease and Phosphatase Inhibitor 
Cocktail (ThermoFisher, 78440). The lysate was separated by centrifugation (18213 xg) and the 
protein harvested in the supernatant was quantified using the Pierce™ BCA Protein Assay Kit 
(ThermoFisher, 23225) following the manufacturer's protocol.  
Western Blotting:  
20-40 µg of protein was diluted to a final volume of 20 µL and mixed with NuPAGE™ 
LDS Sample (4X) (Invitrogen, NP0007) and boiled at 100 °C for 4 min. Samples were then run 
on a NuPAGE™ 4-12% Bis-Tris Protein Gel (Invitrogen, NP0322BOX), transferred to a 
nitrocellulose membrane, and immunoblotted with primary antibodies against the V5 tag raised 
in mouse (Invitrogen, R962-25) at 1:5000, for detection of Dkc1 from the pEF-DEST51 
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constructs, and GAPDH raised in mouse (abcam, ab9484) at 1:10000, for loading control, and 
with the secondary antibody IRDye® 680RD Donkey anti-Mouse IgG (H + L), 0.1 mg (Li-Cor, 
P/N 925-68072) at 1:10000 for visualization using the Li-Cor Odyssey Imaging System. Signal 
intensity of bands was quantified in ImageJ. Dkc1 expression was normalized to GAPDH 
expression in all samples and averaged across samples of the same condition. Bar graphs 
presenting expression of proteins from western blots were generated in GraphPad Prism 7. 
 
Results 
Knockdown of pseudouridine synthases by RNAi  
To test the impact of the two members of the box H/ACA snoRNP Dkc1 and Nop10 on 
regulation of stem cell (SC) homeostasis in mESCs, we designed and constructed plasmids 
expressing shRNAs for the knockdown of Dkc1, Nop10, Trub1, and GFP. Trub1 is an RNA 
independent PUS that is not suspected to be of importance in the maintenance of a SC state, as it 
is not differentially expressed between SCs and differentiated cells (Cinghu et al. 2014). As the 
predominant mRNA PUS (Safra et al. 2017), Trub1 served as a control for mRNA 
pseudouridylation. By controlling for mRNA pseudouridylation, the impact of the box H/ACA 
snoRNP could be distinguished from the impact, if any, of mRNA pseudouridylation on ESC 
homeostasis. The shRNA targeting GFP served as a negative control for transfection conditions 
and shRNA production. Multiple shRNAs were tested for each gene due to potential variability 
in knockdown efficiency between shRNAs and off-target effects. Each of these plasmids was 
tested for knockdown efficiency and impact on gene expression by transfection into mESCs 
followed by antibiotic selection, then RNA extraction and RT-qPCR to determine the levels of 
expression of the PUSs along with expression of stem cell markers (Sox2, Nanog, Oct4). A 
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significant knockdown of the genes of interest in given condition when compared to the shGFP 
negative control indicates a functional shRNA for that gene. A decrease in expression of the 
three SC markers when compared to the shGFP negative control would indicate a loss of stem 
cell phenotype and disruption in stem cell homeostasis.  
 
Figure 2: (A) Knockdown of Dkc1 by shDkc1A (0.22 (p = 0.0103), n = 3) and shDkc1B (0.09 (p = 0.0001), n = 4). 
(B) Expression of Sox2 in knockdowns of Dkc1 by shDkc1A (ns) and shDkc1B (0.30 (p = 0.0061)). (C) Expression 
of Nanog in knockdowns of Dkc1 by shDkc1A (0.59 (p = 0.0399)) and shDkc1B (0.20 (p = 0.0028)) (D) Expression 
of Oct4 in knockdowns of Dkc1 by shDkc1A (ns) and shDkc1B (0.49 (p = 0.0183)). Error bars represent standard 
error of the mean (SEM). 
 
Three shRNAs (shDkc1A, B, & C) were tested for knockdown of Dkc1 with one (shDkc1 
C) being lethal to cells after transfection (data not presented). shDkc1A and shDkc1B both 
showed significant knockdown of Dkc1 with 0.22 (p = 0.0103) and 0.09 (p = 0.0001) fold 
expression of Dkc1 respectively (Figure 2A). shDkc1A resulted in a slightly significant 
reduction in expression of Nanog, with a 0.59 fold expression (p = 0.0399) relative to shGFP, but 
no significant change in Sox2 and Oct4 expression (Figure 2B-D). However, shDkc1B showed a 
significant reduction in all three stem cell markers, with a 0.30 fold expression (p = 0.0061) of 
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Sox2, an 0.20 fold expression (p = 0.0028) of Nanog, and a 0.49 fold expression (p = 0.0183) of 
Oct4 (Figure 2B-D).  
 
Figure 3: (A) Knockdown of Nop10 by shNop10A (0.11 (p = 0.0002), n = 4) and shNop10C (0.22 (p = 0.0019), n = 
4) (B) Expression of Sox2 in knockdowns of Nop10 by shNop10A (0.52 (p = 0.0462)) and shNop10C (ns) (C) 
Expression of Nanog in knockdowns of Nop10 by shNop10A (0.31 (p = 0.0071)) and shNop10C (0.77 (p = 0.0215)) 
(D) Expression of Oct4 in knockdowns of Nop10 by shNop10A (ns) and shNop10C (ns). Error bars represent 
standard error of the mean (SEM). 
 
Three shRNAs (shNop10A, B, & C) were tested for the knockdown of Nop10. shNop10A 
and shNop10C both showed significant knockdown of Nop10 with 0.11 fold expression (p = 
0.0002) and 0.22 fold expression (p = 0.0019) of Nop10 respectively (Figure 3A), while 
shNop10B did not show significant knockdown of Nop10 (p = 0.0949) (data not presented). 
shNop10A also showed a significant reduction in expression of Sox2, 0.52 fold expression (p = 
0.0462), and Nanog, 0.31 fold expression (p = 0.0071), but no significant change in Oct4 
expression (Figure 3B-D). shNop10C showed only significant changes in expression of Nanog, 
with a 0.77 fold expression (p = 0.0215), but no significant changes in expression of Sox2 and 
Oct4 (Figure 3B-D). 
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Figure 4: (A) Knockdown of Trub1 by shTrub1A (0.11 (p = 0.0001), n = 4) and shTrub1B (0.15 (p = 0.0003), n = 
4) (B) Expression of Sox2 in knockdowns of Trub1 by shTrub1A (ns) and shTrub1B (ns) (C) Expression of Nanog 
in knockdowns of Trub1 by shTrub1A (0.36 (p = 0.0051)) and shTrub1B (ns) (D) Expression of Oct4 in 
knockdowns of Trub1 by shTrub1A (0.78 (p = 0.0388)) and shTrub1B (ns). Error bars represent standard error of 
the mean (SEM). 
 
Two shRNAs (shTrub1A and shTrub1B) were tested for the knockdown of Trub1. Both 
shTrub1A and shTrub1B showed significant knockdown of Trub1 with 0.11 (p = 0.0001) and 
0.15 (p = 0.0003) fold expression of Trub1 respectively (Figure 4A). shTrub1A showed a 
decrease in expression in Nanog, 0.36 fold expression (p = 0.0051), and Oct4, 0.78 fold 
expression (p = 0.0388), but no change in expression of Sox2 (Figure 4B-D). However, 
shTrub1B showed no change in expression of any of the three stem cell markers tested (Figure 
4B-D).            
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Figure 5: Alkaline phosphatase staining of PUS knockdowns. Red colonies indicate a stem cell phenotype. shGFP 
control show little to no differentiation, as evidenced by dark red colonies and few cells outside of colonies. 
Knockdown conditions were determined to have no, mild (shTrub1A, shTrub1B), moderate (shNop10A, shNop10C, 
shDkc1A), or severe differentiation (shDkc1B). *shTrub1B was split 1:3 at day 1 to ensure appropriate cell density 
for staining.  
 
Alkaline phosphatase (AP) is known to be expressed at high levels on the surface of 
pluripotent cells, and can be used as a marker for pluripotency (Pera, Reubinoff, and Trounson 
2000, Thomson et al 1998). This stain uses a substrate of AP that turns dark red on contact with 
AP; therefore, red color is indicative of a stem cell phenotype. Loss of staining as well as the loss 
of the compact, colony morphology indicative of ESCs indicates differentiation. The AP staining 
of the shGFP sample showed that these cells maintained a stem cell phenotype. AP staining of 
mESCs after shRNA knockdown of Dkc1, Nop10, and Trub1 was categorized into four 
categories: no differentiation: no distinction between the sample and control, mild 
differentiation: dark red staining but a larger number of cells outside of colonies (shTrub1A), 
moderate differentiation: light red staining and a larger number of cells outside of colonies 
(shNop10A, shNop10C), and severe differentiation: very light red staining and a large portion of 
cells outside of colonies (shDkc1B) (Figure 5).  
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Table 1: Summary of knockdown efficiency, expression of stem cell markers, phenotypic 
evaluation of AP staining, and assessment of stem cell homeostasis. (Abbreviations: Sev. – 






















0.22 No change 0.59 No change Mod. diff. No 
shDkc1B 
Dkc1 
0.09 0.30 0.20 0.49 Sev. diff. Yes 
shNop10A 
Nop10 
0.11 0.52 0.31 No change Mod. diff.  No 
shNop10C 
Nop10 
0.22 No change 0.77 No change Mod. diff.  No 
shTrub1A 
Trub1 
0.11 No change 0.36 0.78 Mild diff.  No 
shTrub1B 
Trub1 
0.15 No change No change No change Mild diff.  No 
 
 Using the criteria of a reduction in expression in all three stem cell markers, Sox2, Nanog, 
and Oct4, and a visual determination of loss of stem cell phenotype by AP staining, knockdown 
of Dkc1 by shDkc1B was determined to cause a defect in ESC homeostasis (Table 1). While the 
less significant knockdown of Dkc1 by shDkc1A and knockdown of Nop10 by shNop10A and 
shNop10C lead to a reduction in some stem cell makers and some differentiation phenotype, they 
were not determined to have a true loss in stem cell homeostasis because expression of all three 
markers was not modulated (Table 1). Furthermore, knockdown of Trub1 by shTrub1A and 
shTrub1B was also not determined to lead to a defect in ESC homeostasis, despite variability in 





Rescue of loss of stem cell phenotype by overexpression of Dkc1  
 Once we determined that the knockdown of Dkc1 resulted in a loss of stem cell 
homeostasis, the question remained if this change was dependent upon the pseudouridylation 
activity of Dkc1. To determine if Dkc1’s catalytic activity is necessary for mESC homeostasis, 
we developed a genetic rescue assay (Figure 6A). This assay makes use of a co-transfection 
system of pLKO-shDkc1B, which results in knockdown of endogenous Dkc1 expression, and 
pEF-DEST51 plasmids overexpressing V5-tagged Dkc1. ShDkc1B was selected due to its robust 
knockdown of Dkc1, significant changes in all three stem cell markers, and notable loss of stem 
cell phenotype by AP staining. While the shRNA would lead to knockdown of endogenous 
Dkc1, we generated an shRNA resistant (shBR) mutant of Dkc1, which could be simultaneously 
overexpressed. This was done by introducing a series of silent mutations in the region of the 
Dkc1 gene that is targeted by shDkc1B using mutagenesis PCR. In addition to the resistance 
mutation, a catalytically inactive version of Dkc1 was generated by the conversion of an aspartic 
acid (D) residue in the catalytic site of Dkc1 to an alanine (A) (D125A) in the pEF-DEST51 
vector by mutagenesis PCR. This resulted in the generation of four independent plasmids for the 
exogenous expression of Dkc1, pEF-DEST Dkc1, pEF-DEST Dkc1 D125A, pEF-DEST Dkc1 
shBR, pEF-DEST Dkc1 D125A shBR. Exogenous expression of Dkc1 from each of the plasmids 
was visualized by western blot. Dkc1 expression was determined by α-V5 western blot, and this 
expression was normalized to GAPDH expression (Figure 6B). Although there was variability in 
expression between plasmids, each plasmid expressed Dkc1 protein. The variability may be due, 
in part, to differences in transfection efficiency between samples as antibiotic selection was not 
used for these transient transfections. 
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Figure 6: (A) Schematic representation of the co-transfection system of pLKO shDkc1B and pEF-DEST plasmid 
expressing Dkc1 that is resistant to knockdown by shDkc1B (Dkc1 shBR), both catalytically active (WT) and 
catalytically inactive (D125A). (B) Western blot showing expression of Dkc1 and the various mutants (Dkc1 
D125A, Dkc1 shBR, Dkc1 D125A shBR) from the pEF-DEST51 vector after transient transfection in mESCs. (C) 
Western blot showing expression of Dkc1 and various mutants (Dkc1 D125A, Dkc1 shBR, Dkc1 D125A shBR) 
from pEF-DEST51 constructs in co-transfection with pLKO shDkc1B after transient transfection in mESCs. (D) 
Quantification of expression of Dkc1 and various mutants from pEF-DEST51 constructs in co-transfection with 
pLKO shDkc1B. Error bars represent standard error of the mean (SEM). 
  
Once baseline protein expression was established from the pEF-DEST51 plasmids, the 
next step was to test the co-transfection system where the shRNA expressing plasmids (pLKO 
shDkc1B) and the various pEF-DEST Dkc1 plasmids (wild type;WT, D125A, shRNA resistant, 
and D125A shRNA resistant) were both introduced into mESCs. To test the expression of Dkc1 
protein in this co-transfection system, cells were transiently transfected with both plasmids and 
harvested two days after transfection. Dkc1 protein levels were detected by α-V5 western blot, 
showing that Dkc1 shBR plasmids have exogenous Dkc1 expression in a co-transfection system 
with shDkc1B, while non-resistant Dkc1 plasmids resulted in extremely low exogenous Dkc1 
expression (Figure 6C-D). Therefore, this co-transfection system was determined to be a valid 
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system for the introduction of an shRNA for the knockdown of Dkc1 and exogenous expression 
of Dkc1 and the associated mutants in mESCs.  
 
Figure 7: (A) Knockdown of Dkc1 in pEF-DEST and pLKO co-transfection system. shDkc1B + pEF-DEST empty 
vector (EV) (0.21 fold expression (p < 0.0001)). Significant increases in expression of Dkc1 were seen in co-
transfection of pLKO shDkc1B and pEF-DEST Dkc1 D125A (2.20 fold expression (p = 0.0102)), Dkc1 shBR (2.35 
fold  expression (p = 0.0306)), and Dkc1 D125A shBR (2.43 fold expression (p = 0.0105) when compared to 
shDkc1B + pEF-DEST EV. A non-significant increase in Dkc1 expression was seen in co-transfection of pLKO 
shDkc1B and pEF-DEST Dkc1 (2.29 fold expression (p = 0.0907)) when compared to shDkc1B + pEF-DEST EV. 
(B) Expression of Sox2 in co-transfection of pLKO shDkc1B and pEF-DEST plasmids. shDkc1B + pEF-DEST EV 
(0.57 fold expression (p = 0.0204)). No significant changes in Sox2 expression were observed in overexpression of 
Dkc1 or mutant versions when compared to shDkc1B + pEF-DEST EV. (C) Expression of Nanog in co-transfection 
of pLKO shDkc1B and pEF-DEST plasmids. shDkc1B + pEF-DEST EV (0.41 fold expression (p = 0.0005)). No 
significant changes in Nanog expression were observed in overexpression of Dkc1 or mutant versions when 
compared to shDkc1B + pEF-DEST EV. (D) Expression of Oct4 in co-transfection of plKO shDkc1B and pEF-
DEST plasmids. shDkc1B + pEF-DEST EV (ns). No significant changes in Oct4 expression were observed in 
overexpression of Dkc1 or mutant versions when compared to shDkc1B + pEF-DEST EV, except a in the case of 
shDkc1B + Dkc1 shBR (1.40 fold expression (p = 0.0389)). (E) Western blot showing expression of exogenous 
Dkc1 and various mutants from pEF-DEST51 constructs in co-transfection with pLKO shDkc1B at four days post-
transfection. Error bars represent standard error of the mean (SEM). 
 
The co-transfection system was then adapted to model the shRNA protocol by expanding 
to a four day time course, with transfection at day zero, expansion of transfections at day 1, 
selection with puromycin and blasticidin at day 2, and harvest of RNA at day 4 post-transfection. 
In addition to the combination of pLKO shDkc1B and the four pEF-DEST Dkc1 plasmids, 
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pLKO shGFP and pLKO shDkc1B were also co-transfected with the empty pEF-DEST51 
plasmid (EV) to serve as controls for transfection conditions and shDkc1B knockdown of Dkc1. 
In the co-transfection system, shDkc1B had less efficient knockdown of Dkc1 (0.21 fold 
expression (p < 0.0001)) when compared to the pLKO only transfection system (0.09 fold 
expression (p = 0.0001)) (Figure 7A & 2A). This corresponded to a lesser difference in 
expression of stem cell markers, with significant reduction in expression of Sox2 (0.57 fold 
expression (p = 0.0204) in co-transfection vs. 0.30 fold expression  (p = 0.0061) in pLKO only 
transfection) and Nanog (0.41 fold expression (p = 0.0005) in co-transfection vs. 0.20 fold 
expression (p = 0.0028) in pLKO only transfection) and a non-significant reduction in expression 
of Oct4 (vs. 0.49 fold expression (p = 0.0183) in pLKO only transfection) (Figure 7B-D, 2B-D).  
Although there was clear exogenous expression of Dkc1 protein from the shRNA 
resistant pEF-DEST plasmids in the co-transfection system at two days after transfection, Dkc1 
mRNA levels were not restored at four days after transfection. From all four pEF-DEST Dkc1 
plasmids, there was only a 2.20-2.43 fold expression of Dkc1 when compared to the knockdown 
condition (Figure 7A). Compared to the shGFP+EV control, each of the pEF-DEST plasmids 
had fold expression of Dkc1 in the range of 0.46-0.51, indicating overexpression of Dkc1 from 
the pEF-DEST vectors was not enough to restore Dkc1 expression to levels without knockdown 
(Figure 7A).  Additionally, when compared to the shDkc1B+EV control, there were no 
significant changes in stem cell markers between any of the rescue conditions, except for a slight 
and mildly significant increase in Oct4 expression in the catalytically active, shRNA resistant 
(shDkc1B+Dkc1 shBR) condition (Figure 7B-D).  In order to determine if exogenous Dkc1 was 
still being produced at the time point of RNA harvest, protein was harvested at the same time 
point (day 4 post-transfection) in the same conditions (expansion on day 1 and antibiotic 
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selection on day 2) and analyzed by western blot. This blot showed no detectable exogenous 
expression of Dkc1 at four days post-transfection in any of the rescue conditions (Figure 7E). 
 
Discussion 
 Due to the high expression of proteins of the box H/ACA snoRNP in stem cells (Cinghu 
et al 2014) and previous findings that Dkc1 is a regulator of stem cell marker expression (Fong et 
al 2014), it was anticipated that the knockdown of the RNA dependent PUS Dkc1 as well as the 
box H/ACA snoRNP member Nop10, which is essential for the pseudouridylation function of 
Dkc1 (Charpentier et al 2005, Li et al 2011), would lead to a loss of stem cell homeostasis, as 
measured by expression of stem cell markers and phenotypic staining for stem cell colonies. This 
finding was confirmed, particularly in the case of Dkc1, where an approximately 90% efficient 
knockdown of Dkc1 by shDkc1B (fold expression 0.09) led to a disruption in stem cell 
homeostasis. A less efficient knockdown by shDkc1A (fold expression 0.22) lead to some 
changes in stem cell marker expression, further supporting the claim that Dkc1 expression can 
impact a stem cell phenotype, although it appears that Nanog expression is most readily 
impacted by a reduction in Dkc1 expression. Furthermore, knockdown of Nop10 by shNop10A 
and shNop10C also resulted in changes in expression of some stem cell markers, but not full loss 
of stem cell homeostasis. This discrepancy between the phenotypic response of stem cells to the 
knockdown of Dkc1 and the knockdown of Nop10 was to be expected, as Dkc1 is the catalytic 
element of the box H/ACA snoRNP, so loss of this protein would render the complex non-
functional. While Nop10 is an important structural component of the box H/ACA snoRNP, 
reduced expression by knockdown of Nop10 may still result in the assembly of some small 
number of functional box H/ACA snoRNP complexes.  
 24 
The results from RT-qPCR analysis of stem cell markers in Dkc1 and Nop10 
knockdowns supports the finding that a stem cell phenotype can be modulated by the expression 
of proteins in the box H/ACA snoRNP, and that Nanog is particularly responsive to changes in 
expression of the RNA-dependent PUS complex. This finding is interesting within the traditional 
dogma of the master regulators, in which Nanog, Oct4, and Sox2 act in partnership through 
transcriptional maintenance of pluripotency. However, studies since the identification of these 
three factors have found that Nanog expression is highly variable in ESCs, while expression of 
Oct4 and Sox2 is fairly homogeneous (Silva and Smith 2008). Additionally, cells lacking Nanog 
can remain undifferentiated and pluripotent, but these cells have a greater tendency to 
differentiate (Chambers et al. 2007, Mitsui et al. 2003). This suggests that Nanog stabilizes the 
pluripotent state, while not being essential for the maintenance of pluripotency in ESCs (Jaenisch 
and Young 2008, Chambers et al. 2007). Therefore, a change in Nanog expression without a 
change in expression of the other two stem cell markers, may indicate a loss of stability in ESC 
homeostasis without a full loss of homeostasis, which could be a kind of priming prior to 
differentiation. This finding is also in line with previous literature that identifies Dkc1 as a co-
activator along with Oct4 and Sox2 of Nanog gene expression in ESCs (Fong et al. 2014).   
 The knockdown of Trub1 was investigated to determine if changes in stem cell 
phenotype as a result of knockdown of the RNA-dependent PUS complex would be seen in an 
RNA-independent PUS that is not highly expressed in mESCs when compared to differentiated 
cells. Even though both shTrub1A (fold expression 0.11) and shTrub1B (fold expression 0.15) 
had similar knockdown efficiency of Trub1, there were marked differences in stem cell marker 
expression between the two shRNAs. One potential explanation for this finding is off-target 
effects of the shTrub1A or shTrub1B shRNA. By potentially targeting mRNAs that are not 
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encoding for Trub1, these shRNAs may have had additional impacts on mESC gene expression 
that cannot be attributed to changes in Trub1 expression. Therefore, we cannot conclude if Trub1 
itself regulates expression of the stem cell markers Sox2, Nanog, and Oct4, or if the changes in 
stem cell markers and phenotype after knockdown of Dkc1 and Nop10 are specific to their 
identity as members of the RNA-dependent PUS complex the box H/ACA snoRNP, not due to 
general pseudouridylation activity.   
 A co-transfection system was developed to simultaneously knockdown endogenous 
expression of Dkc1 and exogenously express either catalytically active (WT) or inactive 
(D125A) Dkc1 that were resistant to knockdown by shDkc1B (shBR), in order to determine if 
the PUS function of Dkc1 is essential for the maintenance of stem cell homeostasis. The efficacy 
of the resistance mutations was confirmed by transient co-transfection of pLKO shDkc1B and 
the four pEF-DEST51 plasmids, which showed exogenous expression of Dkc1 from shRNA 
resistant plasmids in the presence of shDkc1B. This short-term screen was interpreted as a 
validation of the co-transfection system for exogenous expression of Dkc1 in the presence of 
shDkc1B. This system allowed us to explore if expression of catalytically active or inactive 
Dkc1 has an impact on the expression of stem cell markers when endogenous Dkc1 expression is 
reduced by shRNA, thus discerning if the pseudouridylation activity of Dkc1 is required for the 
maintenance of a stem cell state.  
 The co-transfection system was then used to evaluate rescue of loss of stem cell 
homeostasis by overexpression of Dkc1 with and without pseudouridylation activity. In the co-
transfection system, knockdown of Dkc1 by shDkc1B was less efficient than in the pLKO only 
knockdown condition. This corresponded to a less significant disruption in stem cell state, as 
measured by stem cell marker expression, in the co-transfection system when compared to the 
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pLKO only knockdown condition. At four days after transfection, Dkc1 expression in the rescue 
conditions was higher than that of the knockdown condition (2.2-2.4 fold expression), but did not 
reach levels similar to stem cells without knockdown of Dkc1. This level of exogenous Dkc1 
expression was greater than the level at which a full disruption in stem cell state was seen in the 
knockdown conditions, but expression of all three stem cells markers were not rescued to levels 
of shGFP control cells. At the level of exogenous Dkc1 expression seen in all four rescue 
conditions, there were no changes in expression of stem cell markers between the knockdown 
condition and any of the rescue conditions, with the exception of a small and slightly significant 
increase in Oct4 expression in the shDkc1B + Dkc1 shBR condition. Therefore, we cannot draw 
conclusions about the impact of pseudouridylation function of Dkc1 on expression of stem cell 
markers in mESCs.  
 Although we were able to confirm the functionality of the co-transfection system for 
overexpression of Dkc1 and its mutants in a short term screen, we were not able to show that this 
functionality was retained as time progressed. Potential explanations for this finding are 
ineffective selection of pEF-DEST51 containing cells during the antibiotic selection stage of the 
experimental design, improper folding of exogenous Dkc1 proteins due to the presence of a 6X-
His and V5-tag on the C-terminal end of each protein leading to lack of functionality of 
exogenous Dkc1 and protein degradation, or silencing of transcription from the pEF-DEST51 
plasmid over time by epigenetic modification such as methylation of the EF-1α promoter. In 
order to test the likelihood of these hypotheses further experimentation with the pEF-DEST51 
plasmids, including baseline protein expression after selection and four days after transfection, 
need to be conducted. Furthermore, re-cloning of the Dkc1 overexpression constructs to have an 
N-terminal tag may aid in loss of functionality due to improper folding. These steps must be 
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taken first in order to determine if the pseudouridylation function of Dkc1 is responsible for its 
impacts on stem cell phenotype and homeostasis.  
 Previous literature had identified the proteins of the box H/ACA snoRNP as potentially 
important for the maintenance of a stem cell state (Cinghu et al 2014) and Dkc1 as a co-activator 
of Sox2/Oct4 mediated gene expression (Fong et al 2014), but its role as a PUS in the 
maintenance of stem cell homeostasis had not been fully explored. Through shRNA mediated 
knockdown of Dkc1, we were able to establish significant changes in all three stem cell markers 
(Sox2, Nanog, and Oct4) as well as phenotypic changes and loss of AP activity, indicative of 
differentiation. Furthermore, we were able to establish that knockdown of Nop10, another 
essential component of the box H/ACA snoRNP, lead to changes in expression of stem cell 
markers but not a full disruption of stem cell homeostasis. These findings confirm those in 
previous literature that expression of the box H/ACA snoRNP proteins is essential for stem cell 
homeostasis, and we have now established by RT-qPCR that expression of the three master 
regulators of stem cell identity are modulated by knockdown of Dkc1. However further work is 
still needed to establish if the relationship between Dkc1 and stem cell phenotype is due to its 
function as a PUS. Despite the lack of functional connection drawn from these experiments, the 
validation of Dkc1 as essential for the maintenance of a stem cell state furthers the goal of 
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Appendix Table 1: shRNA Oligonucleotides 
Underlined bases indicate the portion of the shRNA that is complementary to the target gene in the forward oligos. 
Bolded bases indicate the hairpin region of the shRNA, as well as a restriction site for the enzyme XhoI.  
 
Target 
Gene Oligo  Oligo Sequence 





























































Trub1 shTrub1B R 
5'-
AATTCAAAAAGCAGACATTGAAAGTCGGACACTCGAGTGT
CCGACTTTCAATGTCTGC-3'   
 
 
Appendix Table 2: Sequencing Primers 
 
Primer Primer Sequence 
pLKO seq 1 5'-CAAGGCTGTTAGAGAGATAATTGG-3' 
EF-alpha seq 1 5'-TCAAGCCTCAGACAGTGGTTC-3'  
Dkc1 seq 2 5'-ACCTACATTCGGACACTATGC-3'  
 
 
Appendix Table 3: Mutagenesis Primers 
Bolded and underlined bases are the mutated bases introduced by these primers through mutagenesis PCR indicated 
on the forward primers 
 
Primer Primer Sequence 
Dkc1 D125A F 5’-CACAGTGGCACACTAGCTCCCAAAGTGACTGGT-3'  














Appendix Table 4: RT-qPCR Primers 
 
Target Gene Primer Primer Sequence 
Actin Actin F 5'-AAGGCCAACCGTGAAAAGAT-3' 
Actin Actin R 5'-GTGGTACGACCAGAGGCATAC-3' 
Dkc1 Dkc1 F 5'-GGAGATTGGGGACTATATCAG-3' 
Dkc1 Dkc1 R 5'-TCACTTTGGGATCTAGTGTGCC-3' 
Nop10 Nop10 F 5'-ATGTTTCTCCAATATTACCTCAACG-3'  
Nop10 Nop10 R 5'-AAGCGTTTCTTGATGGTGATTCG-3'  
Trub1 Trub1 F 5'-AAGCTGGAATGCCTTCTCCAG-3' 
Trub1 Trub1 R 5'-TTTCCCCAGTTGTCCGATGGTG-3'  
Sox2 Sox2 F 5'-GAACGCCTTCATGGTATGGT-3' 
Sox2 Sox2 R 5'-TTGCTGATCTCCGAGTTGTG-3' 
Nanog Nanog F 5'-AAGCAGAAGATGCGGACTGT-3' 
Nanog Nanog R 5'-ATCTGCTGGAGGCTGAGGTA-3' 
Oct4 Oct4 F 5'-CCAATCAGCTTGGGCTAGAG-3' 
Oct4 Oct4 R 5'-CCTGGGAAAGGTGTCCTGTA-3' 
 
 
 
